Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT01177852Phase 3Withdrawn
Phase 3, randomised, open-label trial of Notuss in cough and acute rhinitis (2 arms), sponsored by Aché Laboratórios Farmacêuticos. Primary endpoint: Improvement of nasal congestion and cough at 2 days. Planned start Oct 2011; status: withdrawn.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT01177852.